Breast and Ovarian Oncology Research Program

P. Kelly Marcom, M.D.
Recent Publications

Ellis MJ,Gao F,Dehdashti F,Jeffe DB,Marcom PK,Carey LA,Dickler MN,Silverman P,Fleming GF,Kommareddy A,Jamalabadi-Majidi S,Crowder R,Siegel BA. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.,8/19/2009, (774-80) - JAMA : the journal of the American Medical Association Abstract [More ...]

Il'yasova D,Mixon G,Wang F,Marcom PK,Marks J,Spasojevich I,Craft N,Arredondo F,DiGiulio R. Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration.,8/1/2009, (321-5) - Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals Abstract [More ...]

Bild AH,Parker JS,Gustafson AM,Acharya CR,Hoadley KA,Anders C,Marcom PK,Carey LA,Potti A,Nevins JR,Perou CM. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.,7/28/2009, (R55) - Breast cancer research : BCR Abstract [More ...]

Olson JA Jr,Budd GT,Carey LA,Harris LA,Esserman LJ,Fleming GF,Marcom PK,Leight GS Jr,Giuntoli T,Commean P,Bae K,Luo J,Ellis MJ. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.,5/1/2009, (906-14; discussion 915-6) - Journal of the American College of Surgeons Abstract [More ...]

Tebbit CL,Zhai J,Untch BR,Ellis MJ,Dressman HK,Bentley RC,Baker JA,Marcom PK,Nevins JR,Marks JR,Olson JA Jr. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.,2/18/2009, (-) - Breast cancer research and treatment Abstract [More ...]

Carlson RW,Allred DC,Anderson BO,Burstein HJ,Carter WB,Edge SB,Erban JK,Farrar WB,Goldstein LJ,Gradishar WJ,Hayes DF,Hudis CA,Jahanzeb M,Kiel K,Ljung BM,Marcom PK,Mayer IA,McCormick B,Nabell LM,Pierce LJ,Reed EC,Smith ML,Somlo G,Theriault RL,Topham NS,Ward JH,Winer EP,Wolff AC. Breast cancer. Clinical practice guidelines in oncology.,2/1/2009, (122-92) - Journal of the National Comprehensive Cancer Network : JNCCN No abstract available [More ...]

Partridge AH,Wolff AC,Marcom PK,Kaufman PA,Zhang L,Gelman R,Moore C,Lake D,Fleming GF,Rugo HS,Atkins J,Sampson E,Collyar D,Winer EP. The impact of sharing results of a randomized breast cancer clinical trial with study participants.,6/10/2008, (-) - Breast cancer research and treatment Abstract [More ...]

Olson JA Jr,Marcom PK. Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer.,5/1/2008, (739-40) - Annals of surgery No abstract available [More ...]

Seidman AD,Berry D,Cirrincione C,Harris L,Muss H,Marcom PK,Gipson G,Burstein H,Lake D,Shapiro CL,Ungaro P,Norton L,Winer E,Hudis C. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.,4/1/2008, (1642-9) - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Abstract [More ...]

Demark-Wahnefried W,Case LD,Blackwell K,Marcom PK,Kraus W,Aziz N,Snyder DC,Giguere JK,Shaw E. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.,2/1/2008, (70-9) - Clinical breast cancer Abstract [More ...]



NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.

Duke Comprehensive Cancer Center Accolades